CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.
CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges. Read my analysis of CVS stock here.
This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as declarations from companies such as Citigroup (NYSE:C) and Procter & Gamble (NYSE:PG).
CVS Health Corp (CVS) stock saw a decline, ending the day at $51.96 which represents a decrease of $-0.18 or -0.35% from the prior close of $52.14. The stock opened at $51.43 and touched a low of $50.
Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing that the duo, among leading players in the Medicare Advantage market, are well positioned to benefit from a potential increase in MA payment rates next year.
CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks are trading lower in possible reaction to UnitedHealth's quarterly revenue miss.
Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.83% to 5,949.91 and the Dow Jones Industrial Average DJIA rising 1.
We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other firms that dominated Monday upsurge.
CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from price gouging.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans via Medicaid, Medicare and other programs. Oz would also run the U.S. Affordable Care Act exchanges, which saw 24 million Americans enroll in government-sponsored health care plans in 2024.